Target intelligence / Profile preview

RNA, U6 small nuclear 751, pseudogene (RNU6-751P)

Target
RNU6-751P
Molecular classification
Other (Pseudogene), Non-coding RNA family (snRNA pseudogene)
01

Overview

RNU6-751P is a pseudogene copy related to the highly conserved U6 small nuclear RNA (snRNA), which is a critical RNA component of the spliceosome complex but is itself nonfunctional due to mutations, sequence duplications, or truncations. True U6 snRNA is essential for pre-mRNA splicing in eukaryotic cells, but pseudogene copies like RNU6-751P are generally considered transcriptionally inactive, unable to form functional ribonucleoprotein particles, and do not participate in splicing[3][5]. U6 snRNA pseudogenes are common in vertebrate genomes; they reflect evolutionary duplication events[3][5]. While some pseudogenes can exert indirect regulatory roles or participate in gene regulation as non-coding RNAs, no evidence supports functional activity for RNU6-751P itself[4]. Key context: - U6 snRNA is a bona fide component of the spliceosome, crucial for intron removal[1][3]. - Pseudogenes like RNU6-751P may arise from duplication or retrotransposition but lose the ability to form active molecules[5]. - Most pseudogenes have no direct biological or clinical utility, but emerging research indicates some can regulate gene expression in specific contexts; no such roles are reported for RNU6-751P[4]. No data exist regarding therapeutic targeting, known interacting drugs, clinical utility, or safety issues for RNU6-751P. The entry is generally not considered a valid therapeutic "target" but may be of interest for evolutionary or functional genomics research.

Other names
RNU6-751PU6 small nuclear RNA pseudogene 751RNA U6-751P pseudogene
02

Mechanism of action

None (No mechanisms described, as this is not a drug target)

03

Biological functions

None established (As a pseudogene, RNU6-751P lacks demonstrated biological function)
04

Disease associations

None established (No specific disease involvement known. Some pseudogenes play regulatory roles, but no data for RNU6-751P specifically[4].)
05

Safety considerations

None (Not a therapy target; therefore, no safety concerns apply)
06

Interacting drugs

None (No drugs target this pseudogene)
07

Biomarkers

None (Not used as a biomarker)

Beyond the preview

Go deeper on RNA, U6 small nuclear 751, pseudogene (RNU6-751P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 751, pseudogene (RNU6-751P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call